
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Discovery of Potential SARS-CoV-2 Papain-like Protease Natural Inhibitors Employing a Multi-Phase In Silico Approach
Eslam B. Elkaeed, Ahmed M. Metwaly, Mohamed S. Alesawy, et al.
Life (2022) Vol. 12, Iss. 9, pp. 1407-1407
Open Access | Times Cited: 16
Eslam B. Elkaeed, Ahmed M. Metwaly, Mohamed S. Alesawy, et al.
Life (2022) Vol. 12, Iss. 9, pp. 1407-1407
Open Access | Times Cited: 16
Showing 16 citing articles:
Computer-aided drug discovery of natural antiviral metabolites as potential SARS-CoV-2 helicase inhibitors
Eslam B. Elkaeed, Ibrahim H. Eissa, Abdulrahman M. Saleh, et al.
Journal of Chemical Research (2024) Vol. 48, Iss. 1
Open Access | Times Cited: 8
Eslam B. Elkaeed, Ibrahim H. Eissa, Abdulrahman M. Saleh, et al.
Journal of Chemical Research (2024) Vol. 48, Iss. 1
Open Access | Times Cited: 8
Computer-assisted drug discovery of potential natural inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase through a multi-phase in silico approach
Eslam B. Elkaeed, Bshra A. Alsfouk, Tuqa H. Ibrahim, et al.
Antiviral Therapy (2023) Vol. 28, Iss. 5
Open Access | Times Cited: 12
Eslam B. Elkaeed, Bshra A. Alsfouk, Tuqa H. Ibrahim, et al.
Antiviral Therapy (2023) Vol. 28, Iss. 5
Open Access | Times Cited: 12
Multistaged In Silico Discovery of the Best SARS-CoV-2 Main Protease Inhibitors amongst 3009 Clinical and FDA-Approved Compounds
Ibrahim H. Eissa, Abdulrahman M. Saleh, Sara T. Al‐Rashood, et al.
Journal of Chemistry (2024) Vol. 2024, pp. 1-19
Open Access | Times Cited: 4
Ibrahim H. Eissa, Abdulrahman M. Saleh, Sara T. Al‐Rashood, et al.
Journal of Chemistry (2024) Vol. 2024, pp. 1-19
Open Access | Times Cited: 4
Comprehensive structural and functional analysis of Patuletin as a potent inhibitor of SARS-CoV-2 targeting the RNA-dependent RNA polymerases
Ahmed M. Metwaly, Esmail M. El‐Fakharany, Aisha A. Alsfouk, et al.
Journal of Molecular Structure (2024) Vol. 1311, pp. 138424-138424
Closed Access | Times Cited: 4
Ahmed M. Metwaly, Esmail M. El‐Fakharany, Aisha A. Alsfouk, et al.
Journal of Molecular Structure (2024) Vol. 1311, pp. 138424-138424
Closed Access | Times Cited: 4
Synthesis and characterization of new metal complexes containing azo-indole moiety and anti-leukemia human (HL-60) study of its palladium (II) complex
Yareeb Jawad Sahar, Hasan Shamran Mohammed, Zainab N. Al-Abady
Results in Chemistry (2023) Vol. 5, pp. 100847-100847
Open Access | Times Cited: 9
Yareeb Jawad Sahar, Hasan Shamran Mohammed, Zainab N. Al-Abady
Results in Chemistry (2023) Vol. 5, pp. 100847-100847
Open Access | Times Cited: 9
The Essential Oil of Petroselinum crispum (Mill) Fuss Seeds from Peru: Phytotoxic Activity and In Silico Evaluation on the Target Enzyme of the Glyphosate Herbicide
Oscar Herrera-Calderón, Abdulrahman M. Saleh, Ammar A. Razzak Mahmood, et al.
Plants (2023) Vol. 12, Iss. 12, pp. 2288-2288
Open Access | Times Cited: 9
Oscar Herrera-Calderón, Abdulrahman M. Saleh, Ammar A. Razzak Mahmood, et al.
Plants (2023) Vol. 12, Iss. 12, pp. 2288-2288
Open Access | Times Cited: 9
Repurposing FDA-approved drugs for COVID-19: targeting the main protease through multi-phase in silico approach
Ahmed M. Metwaly, Eslam B. Elkaeed, Aisha A. Alsfouk, et al.
Antiviral Therapy (2024) Vol. 29, Iss. 6
Open Access | Times Cited: 2
Ahmed M. Metwaly, Eslam B. Elkaeed, Aisha A. Alsfouk, et al.
Antiviral Therapy (2024) Vol. 29, Iss. 6
Open Access | Times Cited: 2
The Discovery of Potential SARS-CoV-2 Natural Inhibitors among 4924 African Metabolites Targeting the Papain-like Protease: A Multi-Phase In Silico Approach
Eslam B. Elkaeed, Mohamed M. Khalifa, Bshra A. Alsfouk, et al.
Metabolites (2022) Vol. 12, Iss. 11, pp. 1122-1122
Open Access | Times Cited: 10
Eslam B. Elkaeed, Mohamed M. Khalifa, Bshra A. Alsfouk, et al.
Metabolites (2022) Vol. 12, Iss. 11, pp. 1122-1122
Open Access | Times Cited: 10
An Update of Carbazole Treatment Strategies for COVID-19 Infection
Maria Grazia Bonomo, Anna Caruso, Hussein El‐Kashef, et al.
Applied Sciences (2023) Vol. 13, Iss. 3, pp. 1522-1522
Open Access | Times Cited: 6
Maria Grazia Bonomo, Anna Caruso, Hussein El‐Kashef, et al.
Applied Sciences (2023) Vol. 13, Iss. 3, pp. 1522-1522
Open Access | Times Cited: 6
Arctigenin from Forsythia viridissima Fruit Inhibits the Replication of Human Coronavirus
Jaeyeon So, Jang Hoon Kim, Siyun Lee, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7363-7363
Open Access | Times Cited: 1
Jaeyeon So, Jang Hoon Kim, Siyun Lee, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7363-7363
Open Access | Times Cited: 1
Insights for Future Pharmacology: Exploring Phytochemicals as Potential Inhibitors Targeting SARS-CoV-2 Papain-like Protease
Jawaria Jabeen, Nabeel Ahmed, Zunaira Shahzad, et al.
Future Pharmacology (2024) Vol. 4, Iss. 3, pp. 510-540
Open Access | Times Cited: 1
Jawaria Jabeen, Nabeel Ahmed, Zunaira Shahzad, et al.
Future Pharmacology (2024) Vol. 4, Iss. 3, pp. 510-540
Open Access | Times Cited: 1
A comprehensive molecular docking-based study to identify potential drug-candidates against the novel and emerging severe fever with thrombocytopenia syndrome virus (SFTSV) by targeting the nucleoprotein
Sutirtha Sengupta, Sweta Mohanty, Deblina Rababi, et al.
The Nucleus (2024)
Closed Access
Sutirtha Sengupta, Sweta Mohanty, Deblina Rababi, et al.
The Nucleus (2024)
Closed Access
Discovery of potential FDA-approved SARS-CoV-2 Papain-like protease inhibitors: A multi-phase in silico approach
Ahmed M. Metwaly, Eslam B. Elkaeed, Mohamed M. Khalifa, et al.
Journal of Chemical Research (2024) Vol. 48, Iss. 6
Open Access
Ahmed M. Metwaly, Eslam B. Elkaeed, Mohamed M. Khalifa, et al.
Journal of Chemical Research (2024) Vol. 48, Iss. 6
Open Access
Integrated study of Quercetin as a potent SARS-CoV-2 RdRp inhibitor: Binding interactions, MD simulations, and In vitro assays
Ahmed M. Metwaly, Esmail M. El-Fakharany, Aisha A. Alsfouk, et al.
PLoS ONE (2024) Vol. 19, Iss. 12, pp. e0312866-e0312866
Open Access
Ahmed M. Metwaly, Esmail M. El-Fakharany, Aisha A. Alsfouk, et al.
PLoS ONE (2024) Vol. 19, Iss. 12, pp. e0312866-e0312866
Open Access
Synthesis, Characterization of Metal Complexes with Azo Ligand Containing Indole Ring and Study of Palladium Complex Activity Against Leukemia
Yareeb Jawad Sahar, Hasan Shamran Mohammed
Arabian Journal for Science and Engineering (2023) Vol. 48, Iss. 6, pp. 7797-7805
Closed Access | Times Cited: 1
Yareeb Jawad Sahar, Hasan Shamran Mohammed
Arabian Journal for Science and Engineering (2023) Vol. 48, Iss. 6, pp. 7797-7805
Closed Access | Times Cited: 1
Isolation and in silico investigation of cannflavins from Cannabis sativa leaves as potential anti-SARS-CoV-2 agents targeting the Papain-Like Protease
Amira S. Wanas, Mohamed M. Radwan, Adel A. Marzouk, et al.
Natural Product Research (2023), pp. 1-14
Closed Access | Times Cited: 1
Amira S. Wanas, Mohamed M. Radwan, Adel A. Marzouk, et al.
Natural Product Research (2023), pp. 1-14
Closed Access | Times Cited: 1